Masato Okamoto , Go Ohe , Tetsuya Oshikawa , Hidetomo Nishikawa , Sachiko Furuichi , Hideo Yoshida , Takashi Matsuno , Motoo Saito , Mitsunobu Sato
{"title":"Induction of Th1-type cytokines by lipoteichoic acid-related preparation isolated from OK-432, a penicillin-killed streptococcal agent","authors":"Masato Okamoto , Go Ohe , Tetsuya Oshikawa , Hidetomo Nishikawa , Sachiko Furuichi , Hideo Yoshida , Takashi Matsuno , Motoo Saito , Mitsunobu Sato","doi":"10.1016/S0162-3109(00)00252-6","DOIUrl":null,"url":null,"abstract":"<div><p><span><span><span>We have isolated the lipoteichoic acid (LTA)-related molecule (OK-PSA) from OK-432, a streptococcal preparation, by an affinity chromatography on CNBr-activated Sepharose 4B-bound TS-2 </span>monoclonal antibody (mAb) that neutralizes interferon (IFN)-γ-inducing activity of OK-432. In in vitro experiments using human </span>peripheral blood mononuclear cells<span> (PBMC), OK-PSA induced IFN-γ, interleukin (IL)-2, IL-12, IL-18, tumor necrosis factor (TNF)-α and TNF-β that are generally called “Th1-type cytokines” both in protein and in mRNA levels. Furthermore, the neutralizing test using cytokine-specific antibodies demonstrated that IL-18 plays a most significant role for IFN-γ- and killer cell-inducing ability of OK-PSA among the other cytokines tested. These findings clearly indicated that OK-PSA, an LTA-related molecule, is a main effective component of OK-432, and is a potent inducer of Th1-type cytokines by T cell and natural killer (NK) cell activation mediated by monocytes-derived IL-18, and that it may be a useful </span></span>immunotherapeutic agent for the patients with malignancies better than original OK-432.</p></div>","PeriodicalId":13327,"journal":{"name":"Immunopharmacology","volume":"49 3","pages":"Pages 363-376"},"PeriodicalIF":0.0000,"publicationDate":"2000-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0162-3109(00)00252-6","citationCount":"33","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunopharmacology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0162310900002526","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 33
Abstract
We have isolated the lipoteichoic acid (LTA)-related molecule (OK-PSA) from OK-432, a streptococcal preparation, by an affinity chromatography on CNBr-activated Sepharose 4B-bound TS-2 monoclonal antibody (mAb) that neutralizes interferon (IFN)-γ-inducing activity of OK-432. In in vitro experiments using human peripheral blood mononuclear cells (PBMC), OK-PSA induced IFN-γ, interleukin (IL)-2, IL-12, IL-18, tumor necrosis factor (TNF)-α and TNF-β that are generally called “Th1-type cytokines” both in protein and in mRNA levels. Furthermore, the neutralizing test using cytokine-specific antibodies demonstrated that IL-18 plays a most significant role for IFN-γ- and killer cell-inducing ability of OK-PSA among the other cytokines tested. These findings clearly indicated that OK-PSA, an LTA-related molecule, is a main effective component of OK-432, and is a potent inducer of Th1-type cytokines by T cell and natural killer (NK) cell activation mediated by monocytes-derived IL-18, and that it may be a useful immunotherapeutic agent for the patients with malignancies better than original OK-432.